These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27899242)

  • 21. Corrigendum to "Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview" [Eur. J. Med. Chem. 194 (2020) 112260].
    Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
    Eur J Med Chem; 2020 Nov; 205():112642. PubMed ID: 32750565
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].
    Mendes VIS; Bartholomeusz GA; Ayres M; Gandhi V; Salvador JAR
    Eur J Med Chem; 2016 Nov; 124():1004-1005. PubMed ID: 27783971
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Design, synthesis, and biological evaluation of a new class of histone acetyltransferase p300 inhibitors" [Eur. J. Med. Chem. 180 (2019) 171e190].
    Liu R; Zhang Z; Yang H; Zhou K; Geng M; Zhou W; Zhang M; Huang X; Li Y
    Eur J Med Chem; 2020 Jan; 186():111899. PubMed ID: 31787358
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "New desulfured troglitazone derivatives: Improved synthesis and biological evaluation" [Eur. J. Med. Chem. 187 (2020) 111939].
    Dupommier D; Muller C; Comoy C; Mazerbourg S; Bordessa A; Piquard E; Pawlak M; Piquard F; Martin H; De Fays E; Grandemange S; Flament S; Boisbrun M
    Eur J Med Chem; 2020 Dec; 208():112834. PubMed ID: 32966897
    [No Abstract]   [Full Text] [Related]  

  • 26. Corrigendum to "Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors" [Eur. J. Med. Chem. 197 (2020) 112308].
    Shuai W; Li X; Li W; Xu F; Lu L; Yao H; Yang L; Zhu H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2020 Aug; 200():112464. PubMed ID: 32512484
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "From irreversible to reversible covalent inhibitors: Harnessing the andrographolide scaffold for anti-inflammatory action" [Eur. J. Med. Chem. 204 (2020) 112481].
    Tran QTN; Tan DWS; Wong WSF; Chai CLL
    Eur J Med Chem; 2021 Jan; 209():112943. PubMed ID: 33097302
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "Design and synthesis of novel artemisinin hybrids with potent activities against human colorectal cancer cells in vitro and in vivo" [Eur. J. Med. Chem. 182 (2019) 111665].
    Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
    Eur J Med Chem; 2020 May; 194():112256. PubMed ID: 32220686
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64(10) (2021) 104305].
    Couchonnal E; Bouchard S; Sandahl TD; Pagan C; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Belmalih A; Poujois A; Brunet AS; Lachaux A; Bost M
    Eur J Med Genet; 2021 Nov; 64(11):104341. PubMed ID: 34544667
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109].
    Alvarez RM; García AB; Riesco-Fagundo C; Martín JI; Varela C; Rodríguez Hergueta A; González Cantalapiedra E; Oyarzabal J; Di Geronimo B; Lorenzo M; Albarrán MI; Cebriá A; Cebrián D; Martínez-González S; Blanco-Aparicio C; Pastor J
    Eur J Med Chem; 2021 Nov; 224():113703. PubMed ID: 34284231
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].
    Ojha R; Nepali K; Chen CH; Chuang KH; Wu TY; Lin TE; Hsu KC; Chao MW; Lai MJ; Lin MH; Huang HL; Chang CD; Pan SL; Chen MC; Liou JP
    Eur J Med Chem; 2020 Sep; 201():112404. PubMed ID: 32526554
    [No Abstract]   [Full Text] [Related]  

  • 32. Corrigendum to "A fluorine scan on the Zn
    Zhang B; Liu J; Gao D; Yu X; Wang J; Lei X
    Eur J Med Chem; 2020 Jul; 198():112340. PubMed ID: 32371332
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64 (10) (October 2021) 104305].
    Couchonnal E; Bouchard S; Sandahl TD; Pagan C; Lion-François L; Guillaud O; Habes D; Debray D; Lamireau T; Broué P; Fabre A; Vanlemmens C; Sobesky R; Gottrand F; Bridoux-Henno L; Belmalih A; Poujois A; Collet C; Francou B; Brunet AS; Lachaux A; Misrahi M; Bost M
    Eur J Med Genet; 2022 Mar; 65(3):104453. PubMed ID: 35183456
    [No Abstract]   [Full Text] [Related]  

  • 34. Corrigendum to "Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response" [Eur J Med Chem. 192 2020 112158].
    Wu WC; Liu YM; Lin MH; Liao YH; Lai MJ; Chuang HY; Hung TY; Chen CH; Liou JP
    Eur J Med Chem; 2020 Jun; 196():112329. PubMed ID: 32311605
    [No Abstract]   [Full Text] [Related]  

  • 35. Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942].
    Faraji A; Oghabi Bakhshaiesh T; Hasanvand Z; Motahari R; Nazeri E; Boshagh MA; Firoozpour L; Mehrabi H; Khalaj A; Esmaeili R; Foroumadi A
    Eur J Med Chem; 2021 Mar; 214():113228. PubMed ID: 33550180
    [No Abstract]   [Full Text] [Related]  

  • 36. Corrigendum to "Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates" [Eur. J. Med. Chem. 134(2017) 133-139].
    Tian Z; Si L; Meng K; Zhou X; Zhang Y; Zhou D; Xiao S
    Eur J Med Chem; 2021 Nov; 223():113647. PubMed ID: 34153573
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
    Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
    Eur J Med Chem; 2022 Jan; 228():114041. PubMed ID: 34902733
    [No Abstract]   [Full Text] [Related]  

  • 38. Corrigendum to "Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity" [Eur. J. Med. Chem. 122 (2016) 232-246].
    Gaura R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
    Eur J Med Chem; 2022 May; 235():114277. PubMed ID: 35344906
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of food intake and excretion of metabolites in nephrolithiasis.
    Gordiano EA; Tondin LM; Miranda RC; Baptista DR; Carvalho M
    J Bras Nefrol; 2014; 36(4):437-45. PubMed ID: 25517271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia.
    Hamann M; Meisler MH; Richter A
    Exp Neurol; 2003 Dec; 184(2):830-8. PubMed ID: 14769375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.